Bristol-Myers Squibb supporting efforts to help survivors

Bristol-Myers SquibbBristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donation of antibiotics through Project Hope, an organization providing direct relief to disaster victims. In addition, Bristol-Myers Squibb France is sending medicine to help the injured through Tulipe, an organization that facilitates pharmaceutical company donations to provide an emergency response to people in distress as a result of acute health crises, natural disasters or conflicts.

In addition to the medicines the company has shipped or is sending to help the injured, the Bristol-Myers Squibb Foundation will donate a total of $200,000 to three organizations providing disaster relief. The organizations are:

  • The Catholic Medical Mission Board, which has been working in Haiti since 1912 to provide medicines and much needed supplies and support;
  • The American Red Cross, which is giving $10 million to support a number of relief efforts in the country, many already under way; and
  • Partners in Health, which has been working in Haiti since 1987 to address health care needs.

The Bristol-Myers Squibb Foundation will match two-for-one contributions made by employees in the U.S. and Puerto Rico to the following organizations assisting disaster relief efforts in Haiti:

  • AmeriCares
  • American Red Cross
  • CARE
  • Catholic Medical Mission Board
  • Direct Relief International
  • Doctors Without Borders
  • Partners in Health
  • Project Hope
  • Save the Children

Bristol-Myers Squibb will continue to monitor the situation with its relief partners.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

In mice, stem cells seem to work in fighting obesi…

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality. A wide spectrum of interventions has been proposed for ...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Research shows how a moderate dose of alcohol prot…

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood. A stu...

'Kiss of death' cancer

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negativ...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...